» Articles » PMID: 37928272

Epigenetic Modulations of Immune Cells: from Normal Development to Tumor Progression

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2023 Nov 6
PMID 37928272
Authors
Affiliations
Soon will be listed here.
Abstract

The dysfunction of immune cell development often impairs immunological homeostasis, thus causing various human diseases. Accumulating evidence shows that the development of different immune cells from hematopoietic stem cells are highly fine-tuned by different epigenetic mechanisms including DNA methylation, histone modifications, chromatin remodeling and RNA-related regulations. Understanding how epigenetic regulators modulate normal development of immune cells contributes to the identification of new strategies for various diseases. Here, we review recent advances suggesting that epigenetic modulations can orchestrate immune cell development and functions through their impact on critical gene expression. We also discuss the aberrations of epigenetic modulations in immune cells that influence tumor progression, and the fact that underlying mechanisms affect how epigenetic drugs interfere with tumor progression in the clinic.

Citing Articles

Integrated temporal transcriptional and epigenetic single-cell analysis reveals the intrarenal immune characteristics in an early-stage model of IgA nephropathy during its acute injury.

Xu C, Zhang Y, Zhou J, Zhang J, Dong H, Chen X Front Immunol. 2024; 15:1405748.

PMID: 39493754 PMC: 11528150. DOI: 10.3389/fimmu.2024.1405748.


Development and Validation of a Risk Prediction Model for Frailty in Patients with Chronic Diseases.

Xu Y, Cao W, He Z, Wu N, Cai M, Yang L Gerontol Geriatr Med. 2024; 10:23337214241282895.

PMID: 39444799 PMC: 11497504. DOI: 10.1177/23337214241282895.


Research progress of the netrins and their receptors in cancer.

Gao X, Ye J, Huang X, Huang S, Luo W, Zeng D J Cell Mol Med. 2024; 28(8):e18241.

PMID: 38546656 PMC: 10977403. DOI: 10.1111/jcmm.18241.

References
1.
Cao K, Wang G, Li W, Zhang L, Wang R, Huang Y . Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity. Oncogene. 2015; 34(49):5960-70. PMC: 4672172. DOI: 10.1038/onc.2015.46. View

2.
Qi T, Sun M, Zhang C, Chen P, Xiao C, Chang X . Ascorbic Acid Promotes Plasma Cell Differentiation through Enhancing TET2/3-Mediated DNA Demethylation. Cell Rep. 2020; 33(9):108452. DOI: 10.1016/j.celrep.2020.108452. View

3.
Beguelin W, Popovic R, Teater M, Jiang Y, Bunting K, Rosen M . EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell. 2013; 23(5):677-92. PMC: 3681809. DOI: 10.1016/j.ccr.2013.04.011. View

4.
Lau P, Cheung P . Histone code pathway involving H3 S28 phosphorylation and K27 acetylation activates transcription and antagonizes polycomb silencing. Proc Natl Acad Sci U S A. 2011; 108(7):2801-6. PMC: 3041124. DOI: 10.1073/pnas.1012798108. View

5.
Singh B, Zhang G, Hwa Y, Li J, Dowdy S, Jiang S . Nonhistone protein acetylation as cancer therapy targets. Expert Rev Anticancer Ther. 2010; 10(6):935-54. PMC: 3273412. DOI: 10.1586/era.10.62. View